Advanced Liver Fibrosis

Gastroenterology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Alentis Therapeutics
Alentis TherapeuticsSwitzerland - Allschwil
1 program
1
ALE.F02Phase 11 trial
Active Trials
NCT05939947CompletedEst. Oct 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Alentis TherapeuticsALE.F02

Clinical Trials (1)

A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis

Start: Apr 2023Est. completion: Oct 2024
Phase 1Completed

Related Jobs in Gastroenterology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space